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Aging is the main risk factor for neurodegenerative diseases, including Alzheimer’s
disease (AD). However, evidence indicates that the pathological process begins long
before actual cognitive or pathological symptoms are apparent. The long asymptomatic
phase and complex integration between genetic, environmental and metabolic factors
make it one of the most challenging diseases to understand and cure. In the present
study, we asked whether an environmental factor such as high-fat (HF) diet would
synergize with a genetic factor to affect the metabolic and cognitive state in the
Apolipoprotein E (ApoE4) mouse model of AD. Our data suggest that a HF diet induces
diabetes mellitus (DM)-like metabolism in ApoE4 mice, as well as changes in β-site
amyloid precursor protein-cleaving enzyme 1 (BACE1) protein levels between the two
ApoE strains. Furthermore, HF diet induces anxiety in this AD mouse model. Our results
suggest that young ApoE4 carriers are prone to psychological stress and metabolic
abnormalities related to AD, which can easily be triggered via HF nutrition.
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INTRODUCTION
Aging is the main risk factor for Alzheimer’s disease (AD), which is a complex multifactorial
disease involving both genetic and environmental factors. AD affects about 40 million people
worldwide, with predictions for a dramatic increase in the coming years with the increase in the
aged population (Dacks et al., 2014).
The most common form of the disease, sporadic, late onset AD, strikes on average after the
age of 65, and is strongly linked to the Apolipoprotein E (ApoE) gene on chromosome 19.
ApoE encodes a 299-amino acid, 34-kDa glycoprotein most prevalent in the liver, followed
by the brain. ApoE mediates the transport and clearance of cholesterol, triglycerides, and
other lipids (Li et al., 1988). The three human ApoE isoforms ε2, ε3 and ε4 differ from
one another at residues 112 and 158, affecting their 3-dimensional structure. The ε4 allele
has approximately 20% frequency in the general pooled population and roughly 50% in
patients with AD, however, there is substantial heterogeneity in these prevalence estimates
(Ward et al., 2012). The above finding renders ApoE4 the major genetic risk factor for sporadic
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AD (Rall et al., 1982; Strittmatter and Roses, 1996; Ward et al.,
2012).
Different pathological mechanisms have been proposed to
explain the effect of ApoE4, including mainly defects in the
clearance of the beta-amyloid (Aβ) peptide, lipid and cholesterol
metabolism, inflammation, mitochondrial dysfunction, neuronal
function, and to a lesser extent, amyloid precursor protein
(APP) cleavage (Mahley and Rall, 2000; He et al., 2007;
Castellano et al., 2011; Chen et al., 2012; Dafnis et al.,
2012). In addition, diabetes mellitus (DM) was suggested to
exacerbate the risk of AD associated with ApoE4, as patients
with diabetes who carry the ApoE4 allele are twofold more
likely to develop AD than non-diabetic ApoE4 carriers (Peila
et al., 2002). A possible mechanism specifically linking insulin
resistance to AD in ApoE4 carriers is that Aβ is in part
cleared by the insulin degrading enzyme (IDE). AD patients
carrying the ApoE4 allele have been reported to express
reduced IDE protein and mRNA levels in the hippocampus
(Biessels et al., 2005; Schipper, 2011), suggesting a causal link
between impaired insulin metabolism, either hypoinsulinemia
or insulin resistance, and the pathogenesis of AD (Schipper,
2011).
Diverse metabolic stresses such as described above are
mirrored in part by changes in the phosphorylation of eukaryotic
initiation factor 2 (eIF2α) at serine 51 in cells and specifically in
neurons, leading to changes in translation regulation (Sonenberg
et al., 2000). At the same time, inverse correlation has been
identified between eIF2α phosphorylation and memory or
synaptic plasticity consolidation (Costa-Mattioli et al., 2007).
Several lines of evidence indicate that phosphorylation of eIF2α
or activation of its kinase, double-stranded RNA-activated
protein (PKR), are involved in the pathogenesis of AD (Chang
et al., 2002; Page et al., 2006). We have previously shown that
ApoE4 AD model mice express high phosphorylation levels
of eIF2α in the hippocampus compared to their age matched
ApoE3 controls as early as 4 months of age (Segev et al., 2013).
Furthermore, this increased phosphorylation is correlated with
increased mRNA expression of activating transcription factor4
(ATF4) mRNA both in these mice and in postmortem AD brains
(Segev et al., 2015).
Genome-wide association studies identified ApoE4 as the
only significant gene associated with age-related cognitive
decline in humans (De Jager et al., 2012). Additional studies
suggest that ApoE4 has a detrimental effect on cognition
before the typical signs of AD are apparent (Caselli et al.,
2009). Supporting the above is the fact that we and others
have shown that glial fibrillary acidic protein (GFAP)-ApoE4
expressing human-ApoE4 in astrocytes under the control of
a GFAP promoter, as well as transgenic hAPP-ApoE4 and
human-ApoE4 mice carrying the human ApoE4 gene under
the endogenous ApoE mouse promoter, are impaired in spatial
memory compared with their ApoE3 controls (Raber et al.,
2000; Hartman et al., 2001; Kornecook et al., 2010; Salomon-
Zimri et al., 2014; Segev et al., 2015). However, another
study (Olsen et al., 2012) showed no memory deterioration
in human-ApoE4 mice in the contextual memory of Fear
Conditioning. These conflicting results may be due to the
different mouse strains, but more likely due to the different
protocols used. While Olsen and colleagues used a relatively
strong protocol of two shocks, we used a single shock
paradigm (Olsen et al., 2012; Segev et al., 2013). In our
experience, a stronger shock makes it hard to detect cognitive
differences between the mouse strains at a young age, therefore
to detect changes in memory one needs to use a weaker
protocol.
An additional factor linking metabolic stress to AD, is the
β-site APP-cleaving enzyme 1 (BACE1). BACE1 is the initiator
enzyme for the formation of Aβ, and surprisingly, increased
phosphorylation of eIF2α as a result of metabolic stress, while
decreasing general protein synthesis, increases a subset of
mRNAs such as ATF4 (Costa-Mattioli et al., 2007) and BACE1
(O’Connor et al., 2008). Indeed, increased BACE1 protein levels
and activity have been reported in the brains from AD patients
(Fukumoto et al., 2002). In addition, BACE1 has been studied in
relation to insulin deficiency and obesity. For example, a study
by Devi et al. (2012) suggested that translational mechanisms
through phosphorylation of eIF2αmay underlie the upregulation
of BACE1 associated with insulin deficient diabetes. Another
group showed thatmice lacking BACE1 are lean, resistant to diet-
induced obesity and display increased peripheral tissue insulin
sensitivity with improved whole-body glucose disposal (Meakin
et al., 2012).
In addition to the known symptoms of cognitive impairment,
increased anxiety may occur in up to 70% of AD patients during
the course of their illness (Ferretti et al., 2001), and specifically
patients with e4/e4 show higher anxiety scores than those with
e3/e3 (Robertson et al., 2005).
In the present study, we tested the hypothesis that a
high-fat (HF) diet converges on the ApoE4 allele, resulting
in enhanced attenuation of cognitive abilities and metabolic
phenotype. In order to test this hypothesis, we provided human-
ApoE4 transgenic mice, which express the human ApoE gene
physiologically under the murine ApoE promoter, and their
ApoE3 controls with a HF diet for 20 weeks post- weaning,
after which they were evaluated for metabolic and behavioral
phenotypes. In agreement with others, we show that although
ApoE4 mice gain less weight over time (Huebbe et al., 2015),
they develop DM-like features (Arbones-Mainar et al., 2008;
Pendse et al., 2009). Interestingly, consumption of the HF diet
induces higher anxiety levels in the HF-apoE4 mice compared
with HF-ApoE3 controls. Furthermore, BACE1 protein levels are
increased in the hippocampus of HF-ApoE4 mice. Our findings
point out the importance of convergence of environmental and
genetic factors in the etiology and progression of AD at a young
age, before pathological symptoms are apparent, and propose




Humanized knock-in ApoE3 (B6.129P2-ApoEtm2(ApoE∗3)Mae N8)
and knock-in ApoE4 (B6.129P2-ApoEtm3(ApoE∗4)Mae N8)
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homozygous male mice were supplied by Taconic (Hudson,
NY, USA). All cages were placed in a light and temperature
controlled room, and behavioral tests were conducted during
daylight hours. All animals were handled in accordance with
the University of Haifa regulations and the National Institutes
of Health Guidelines (NIH publication number 8023), and
maintained in a pathogen-free environment.
Animal Treatment
All animal care and procedures were carried out in accordance
with local guidelines and approved by the Animal Care and Use
Committee of the University of Haifa. All efforts were made to
minimize animal suffering and discomfort.
One month old male mice, both ApoE3 and ApoE4, were
weaned, group housed in cages consisting of two or three
littermates and given immediately a diet consisting of 60% fat
(‘‘high fat diet’’, TD.06414, Harlan, WI, USA) ad libitum for a
total of 3 months. Animals were weighed using lab scales and
food intake was inspected on a weekly basis as the difference in
mass between what was given at feeding time and the amount
that was left 1 week later. The same animals were used for
all experiments to assess the influence of the HF diet on the
behavior of the different strains. Animals were sacrificed by
cervical dislocation 2 weeks after the restraint test.
Metabolic Measurements and Plasma
Collection
Peripheral blood glucose was measured using an Accu-chek
Performa glucometer (Roche, Switzerland) after nicking the
tail tip. Non-fasting glucose levels were measured between
10 and 11:30 AM. Mice were deprived of food overnight for
12 h for fasting insulin measurements. Peripheral blood for
insulin was collected by cardiac puncturing, after which mice
were sacrificed. Blood was then diluted in 0.5 M EDTA and
centrifuged for 25 min at 4◦C and 3500 RPM. Plasma Insulin
was determined using Rat/mouse Insulin Elisa kit #EZRMI-13K
(Merck Millipore, Germany) according to the manufacturer’s
instructions.
Fear Conditioning
Fear conditioning was conducted in model chambers, measuring
(25 × 25 × 25) cm internally (Panlab Harvard Apparatus,
Barcelona, Spain). Each chamber was located inside a larger,
insulated plastic cabinet that excluded external light and noise.
The system enabled recording and analysis of the signal
generated by animal movement via a high-sensitivity weight
transducer system. Mice were placed in a chamber (context A
with light [20 W bulb] and a 16-bar metal grid floor) for 120 s,
after which the mice received a 2.9 kHz tone, applied for 30 s
at 80 dB (conditioned stimuli; CS) and a subsequent 0.6 mA
shock applied for 2 s (unconditioned stimuli; US), after which
they remained in the chamber for 60 additional seconds and were
returned to their home cage. The chambers were cleaned with
10% ethanol between successive sets of mice. Animal behavior
was recorded, and the data were analyzed by Freeze Frame
3.0 software (Coulbourn Instruments, Whitehall, PA, USA).
The indication for fear memory was percentage of time spent
freezing.
Elevated Plus Maze
The elevated plus maze (EPM) paradigm was conducted in a
standard plus maze. The maze apparatus consisted of four arms
in a cross position from a neutral central square. The horizontal
arms are defined as ‘‘closed arms’’ (52 cm × 7 cm × 15 cm)
and the vertical arms are defined as ‘‘open arms’’ and have no
protective walls (52 cm× 7 cm). The 50 cm highmaze was placed
on a table in a room with indirect light. At the beginning of
a 10 min test session, each mouse was placed in the middle of
the maze facing the open arms and movement was monitored
and registered by a camera system connected to an Ethovision
XT system (Noldus, Leesburg, VA, USA). Time in closed arms
was expressed as the percentage of time spent in the closed
arms during the duration of the test and body elongation as the
cumulative time the mouse stretched at least half of its body from
a standing position at the center to the area of the open arms.
The maze was cleaned with 10% ethanol between successive
tests.
Tissue Extraction
Mice were injected subcutaneously with ketamine (0.01 mL/g)
and were decapitated after cervical dislocation. Brains were
removed rapidly and frozen using liquid nitrogen. Coronal
sections were cut on a Leica CM3050S cryostat using Richard-
Allan Sec5e blades until the amygdala was exposed and was
dissected from the caudal side. Sections were taken further
on until the hippocampus area was exposed and dissected
similarly. Single or multiple punches were taken to remove
the area in discussion. Hippocampal punches removed the
entire hippocampus, and amygdala punches removed the
basolateral (BLA) area. Punches for each area from both
hemispheres were pooled and stored together for each mouse
in the same tube, then stored at −80◦C until protein level
evaluation.
Western Blotting
Preparation of Cell Extracts
All protein levels were evaluated in hippocampal lysates by
Western blot analysis. Lysates were made by homogenizing
samples in SDS sample buffer. A volume of 15 µl of each
sample was loaded into its respective well in a 26 well
Criterion TGX gel (Bio-Rad, Hercules, CA, USA). Every two
gels were placed in a Criterion electrophoresis cell (Bio-Rad,
CA, USA) and electrophoresed under a 200 mA current
for 90 min. Transfer was done using the Trans-Blot Turbo
Transfer system (Bio-Rad, Hercules, CA, USA) onto 0.45 µm
nitrocellulose membranes (Bio-Rad, Hercules, CA, USA). Blots
were blocked in freshly prepared Tris-buffered saline solution
containing 0.1% Tween 20 (TBST) with 2–5% BSA for 1 h
at room temperature, with agitation. Primary antibodies and
preparation: BACE Rabbit mAB #5606 (Cell Signaling, Danvers,
MA, USA) diluted 1:500 in 4% BSA and 0.1% sodium azide;
total-eIF2α Mouse mAB #2103 (Cell Signaling, MA, USA)
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diluted 1:1000 in 4% BSA and 0.1% sodium azide; phospho-
eIF2α Rabbit mAB #3398 (Cell Signaling, Danvers, MA,
Danvers, USA) diluted 1:1000 in 4% BSA and 0.1% sodium
azide.
Each membrane was incubated overnight with its respective
primary antibody, then washed in TBST three times for 5 min
each. Following this series of washing steps, membranes were left
for an hour incubation with a secondary antibody. Secondary
antibodies were prepared in TBST solution and according to
the specific primary antibody. BACE and p-eIF2α membranes
were incubated in αRabbit antibody (1:10,000), whereas eIF2α
membrane was incubated in αMouse antibody (1:10,000).
Membranes were then developed using an XRS camera and the
data analyzed by Quantity one 1-D Analysis software (Bio-Rad,
Hercules, CA, USA).
Real Time mRNA
Total RNA (1 µg) extraction from the amygdala was
performed using the RNAeasy Lipid Tissue mini kit (QIAGEN,
Netherlands) according to themanufacturer’s recommendations.
Reverse transcription was made using the Invitrogen Superscript
III first strand synthesis (Live technologies, Carlsbad CA, USA).
RNA samples were mixed with random hexamer primers and
were incubated at 65◦C for 5 min and briefly centrifuged. The
samples then underwent a reaction using 10 µl reaction mix
and then incubated again as follows: 5 min in 25◦C then 50◦C
for 50 min. The reaction was terminated at 85◦C for 5 min
and was stored at −20◦C. Real time RT-PCR was performed
in triplicates using the ABI PRISM StepOne plus Sequence
Detector (Life technologies, Grand Island, NY, USA). The
analyzed genes were corticotropin releasing factor (CRF)
primer #205769, CRF1 primer #7762, and NR3c1 primer #8173,
all from the TaqMan Gene Expression Assays primers (Life
Technologies, Grand Island, NY, USA) according to existing
literature.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism6.
Means of two groups were compared with a two-tailed t test or
the Mann-Whitney-Wilcoxon U test. Comparisons of multiple
groups or measurements were analyzed with one-way analysis
of variance (ANOVA) or two-way ANOVA, followed by the
appropriate post hoc tests. All groups were initially checked for
normal distribution of data before proceeding with the analysis.
RESULTS
High-Fat Diet Induces Changes in Anxiety
Behavior Between ApoE3 and ApoE4 Mice
In this study, we hypothesized that consumption of a HF diet
would differentially affect ApoE4 vs. ApoE3 mice cognitively,
i.e., it would further increase their metabolic burden, and as
a consequence, increase differences observed in the behavioral
phenotype of the hippocampal-dependent contextual memory
between the two strains. For this purpose, ApoE4 (n = 21)
and ApoE3 (n = 20) mice in two different batches pooled
for analysis were fed on a HF diet (60% fat) for 20 weeks
from weaning age. At the end of this time period the mice
were tested for behavioral performance in the fear conditioning
paradigm. This test was initially chosen because it had the
strongest phenotype effect, however, unexpectedly, the mice
showed significant differences as early as the conditioning
phase of the foot shock (Figure 1A). HF-ApoE4 mice
showed significantly higher freezing levels than HF-ApoE3
controls (2-way ANOVA repeated measures; F(1,117) = 33.01,
∗∗∗∗P < 0.0001).
These intriguing results prevented us from further testing
our initial hypothesis and prompted us to propose a new
one: HF diet differentially affects stress-like behavior in HF-
ApoE3 vs. HF-ApoE4 mice as indicated in the higher freezing
levels of HF-ApoE4 mice after presentation of the US alone.
In order to test differential anxiety behavior in the two
experimental groups, we used the EPM paradigm. Mice were
placed on a 50 cm high plus maze placed on a table,
with two open and two closed arms for a total exploration
time of 10 min, during which their behavior was recorded.
HF-ApoE4 (n = 10) mice spent significantly more time in
the closed arms compared to HF-ApoE3 (n = 8) mice,
reminiscent of stressful behavior (Hogg, 1996; Figure 1B; Mann
Whitney test, ∗p = 0.0341). There were no differences in
movement/activity between the two mouse strains (data not
shown).
A more detailed analysis of behavior revealed differences in
risk assessment (RA) between the two mouse strains (Blanchard
et al., 1990; Griebel et al., 1995). HF-ApoE4mice exhibited longer
time spent in the stretched attended posture (SAP) compared
to HF-ApoE3 mice (Figure 1C; Unpaired t-test, t(16) = 2.931,
∗∗p= 0.0098), mainly at time points of aborted attempts of entry
into the open arms. RA refers to a pattern of responses such as
scanning, stretch attended posture, and flat back approaching
(Griebel et al., 1997).
HF-ApoE4 Mice do not Express More
Stress-Induced Plasticity in the Amygdala
Compared to HF-ApoE3 Controls
We next asked whether the anxiety behavior seen in young
ApoE4 mice fed on the HF diet is reflected by differences in
expression levels of stress-related neuropeptide mRNA in the
amygdala. The CRF peptide system is critical for the behavioral
response to stressful situations such as anxiety in vertebrates
(Bale and Vale, 2004; Hauger et al., 2006). We thus examined the
amygdala of HF-ApoE4 (n= 10) and HF-ApoE3 (n= 8) mice for
CRF, CRF receptor type1 (CRF1), and glucocorticoid receptor
(NR3C1) mRNA levels. We did not detect any significant
changes in the above factors between the two mouse strains
(Figure 2A).
We have previously shown that young (4month) naïve ApoE4
mice express high ATF4 mRNA levels in the hippocampus
compared with ApoE3 controls (Segev et al., 2015). Here, we
observed that this increase is also apparent in the amygdala
of the mice fed on the HF diet (Figure 2A; Unpaired t-test,
t(15) = 2.831, ∗p = 0.0126), suggesting that the increased
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FIGURE 1 | High-fat (HF) diet induces changes in anxiety behavior
between Apolipoprotein E (ApoE3) and ApoE4 mices. (A) HF-ApoE4 and
HF-ApoE3 mice were placed in an isolated chamber and after 60 s were
introduced with a 2 s 0.5 mA foot shock followed by a 60 s long post-shock
interval. HF-ApoE4 mice showed higher freezing time after the presentation of
the foot shock, compared to HF-ApoE3 mice (Two-Way repeated measures
analysis of variance (ANOVA), F(1,39) = 17.06, #p = 0.0002). (B) Four to five
months old ApoE4 mice and age matched ApoE3 controls that consumed a
HF diet for 20 weeks were placed in an elevated plus maze (EPM) for a period
of 10 min, while their behavior was evaluated. HF-ApoE4 mice spent a longer
time in the closed arms of the EPM (300.7 ± 24.37, n = 10) compared with
ApoE3 mice (183.0 ± 57.18 n = 8; Mann-Whitney test, ∗p = 0.0341).
(C) HF-diet mice were evaluated for cumulative duration of body elongation
stretched posture. ApoE4 mice displayed a significantly longer
(6.304 ± 1.880, n = 10) period of time in the stretched posture, compared to
ApoE3 mice (0.1050 ± 0.05803, n = 8; t(16) = 2.931, ∗∗p = 0.0098). Data are
shown as the mean ± SEM. #Relates to the repeated measuring effect of
freezing between the groups p < 0.05.
expression levels of ATF4 in the central nervous system
(CNS) of ApoE4 mice are not specific to the hippocampus.
We cannot conclude from this, however, that the increased
FIGURE 2 | HF-ApoE4 do not express stress-induced plasticity in the
amygdala compared to HF-ApoE3 mice, but display correlation
between corticotropin releasing factor 1 (CRF1) expression and
freezing percent post foot-shock. Whole amygdala was punched from the
brains of mice maintained on a HF diet, and mRNA was extracted for
evaluation of specific mental stress-related genes as well as the metabolic
stress-related gene activating transcription factor 4 (ATF4). (A) There were no
significant differences between HF-ApoE4 and HF-ApoE3 mice in CRF1
(t(15) = 1.554, p = 0.1411), CRF (t(15) = 0.1911, p = 0.8510), and NR3C1
(t(15) = 0.3328, p = 0.7439). ATF4 expression was higher in HF-ApoE4
(1.449 ± 0.08855, n = 10) compared to HF-ApoE3 mice (1.116 ± 0.05892,
n = 7; t(15) = 2.831, ∗p = 0.0126). (B,C) Correlations; (B) HF-ApoE4 mice
displayed significant correlation between amygdala CRF1 mRNA and foot
shock-dependent freezing percent (p = 0.0052, R2 = 0.6446). (C) However,
there was no significant correlation in HF-ApoE3 mice between amygdala
CRF1 mRNA and freezing percent (p = 0.2656, R2 = 0.2389). Correlation was
analyzed using Pearson r test. Data are shown as the mean ± SEM.
expression levels in the amygdala are due to the consumption
of the HF diet, since the analysis was not performed on the
amygdala of naïve mice. Interestingly, although there were
no significant differences in CRF1 mRNA levels between the
two mouse strains, HF-ApoE4 mice showed a strong and
significant correlation between CRF1 levels and the freezing
percent in response to the foot shock presentation (Figure 2B;
Pearson r = 0.802, ∗∗p = 0.0052), whereas HF-ApoE3 mice
did not show this tendency (Figure 2C; Pearson r = 0.488,
p = 0.2656), suggesting that the anxiety behavior in HF-ApoE4
mice is coordinated, at least in part, by CRF receptors in the
amygdala.
ApoE4 Mice Develop Diabetes Mellitus-like
Metabolic Features Following Maintenance
on a High-Fat Diet
Dysregulation of glucose and insulin homeostasis as well as
obesity are risk factors for the development of AD (Ho et al.,
2004; de la Monte and Wands, 2008; Maesako et al., 2015).
Furthermore, there is growing evidence in support of the
hypothesis that AD represents a form of DM that selectively
affects the brain (de la Monte and Wands, 2008). Here, we
confirm previous work by others (Huebbe et al., 2015), showing
that ApoE4 mice fed on a HF diet gain less weight over
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time, compared with their HF-ApoE3 age matched controls
(Figure 3A; 2-way repeated measures ANOVA, strain effect;
(F(1,16) = 13.54, ∗∗p= 0.0020).
We further demonstrate that consumption of a HF diet alone
is sufficient to cause DM-like metabolic features apparent by
disruption in peripheral glucose and insulin levels in the HF-
ApoE4ADmousemodel (Figures 3B,C). Specifically, HF-ApoE4
(n = 10) mice have lower levels of peripheral plasma insulin
after a 24 h starvation period (t(15) = 4.643, ∗∗∗P = 0.0003),
and higher glucose levels (t(15) = 2.924, ∗P = 0.0105) compared
with HF-ApoE3 (n= 8) controls (Figure 3D). We asked whether
the glucose and insulin levels in the HF-ApoE4/3 mice resemble
those of C57BL/6 mice fed with the same diet (data obtained
from Harlan laboratories), which would suggest whether the
changes are specific to the ε4 allele. C57BL/6 mice fed with this
diet for a period of 17 weeks show glucose levels of 146 mg/dl.
Both HF-ApoE3 and HF-ApoE4 show higher levels of glucose,
however, ApoE4 mice show higher levels (287 mg/dl) compared
to ApoE3 mice. This hypothesis should be further evaluated
by comparing the data to groups of ApoE3 and E4 fed on a
normal diet. Interestingly, HF-ApoE4 mice showed a stronger
correlation between body weight and peripheral serum insulin
levels (Pearson r, ∗∗P= 0.0016) than HF-ApoE3 mice (Pearson r,
∗P= 0.033). Differences between elevations are highly significant
(∗∗∗p= 0.0003657).
High-Fat Diet Promotes Changes in BACE1
Protein Expression in the Hippocampus
Between ApoE3 and ApoE Mice
We have previously shown that phosphorylation of eIF2α is
increased in 4 month old ApoE4 mice (Segev et al., 2015).
As observed before in naïve mice, HF-ApoE4 mice express
higher levels of eIF2α phosphorylation in the hippocampus
compared with HF-ApoE3 controls (Figure 4A; t(27) = 6.367,
∗∗∗∗P < 0.0001). In addition, HF-ApoE4 (n = 10) mice express
higher BACE1 protein levels in the hippocampus compared
to HF-ApoE3 (n = 8) controls (Figure 4B; t(25) = 2.204,
∗P = 0.0369).
Work by others suggests that the increase in BACE1 levels
may be related to the HF consumption and the DM-like
metabolic features (Patil et al., 2006; Zhang et al., 2009; Son
et al., 2012), however, it has never been shown, to the best
of our knowledge, in the ApoE4 AD model. There was no
correlation between hippocampal BACE1 protein levels and
ATF4 mRNA levels in the amygdala. This can be explained by
the different measurements, i.e., mRNA vs. protein, the different
tissues analyzed, i.e., amygdala vs. hippocampus, and the fact
that the differences between the elevations are highly significant
(Figure 4C; F(1,13) = 13.4541, ∗∗P = 0.0028).
DISCUSSION
In agreement with the early emergence and slow progression of
AD, environmental factors are becoming more important in our
consideration of ways to delay the onset of disease symptoms.
Nutrition is one such environmental factor, which is closely
related to both cholesterol metabolism, i.e., ApoE genotype, and
insulin/glucose impaired metabolism, i.e., DM, which are both
risk factors for AD.
We have previously demonstrated that young human-
targeted ApoE4 replacement mice show mild cognitive
impairment (MCI) in the contextual fear conditioning paradigm,
compared with ApoE3 age matched controls (Segev et al., 2013).
Later publications by other groups strengthened these findings
of cognitive deficiency in this mouse strain (Salomon-Zimri
et al., 2014). In our previous experiments with standard diet
fed mice, basal freezing levels in the conditioning phase were
consistently similar between the two groups, suggesting that
the unconditioned stimulus, foot shock, by itself did not cause
behavioral/anxiety differences between the groups. In the present
study, we asked whether a simple, noninvasive intervention such
as a western-like HF diet would have an effect on the metabolism
and/or cognitive behavior of an AD-relevant mouse model,
the ApoE4 mice. We initially hypothesized that the cognitive
impairments in young naïve ApoE4 mice (Segev et al., 2013)
would be worsened by a HF diet. To this end, the AD-relevant
model mice and their controls, ApoE3 mice, were given a
western-like HF diet from weaning age until they reached 4
months, the age in which we previously detected behavioral
abnormalities and eIF2α increased phosphorylation (Segev et al.,
2013). However, unexpectedly, ApoE4 mice displayed higher
anxiety levels as early as the presentation of a foot shock on
the conditioning day of the fear conditioning paradigm. Due
to these results the mice were not further evaluated for the
memory of the fear conditioning. Instead, they were analyzed
for anxiety in the EPM. The results suggest that expression
of human-ApoE4 allele renders mice fed on a western-like
diet more susceptible to mental stress. It should be noted that
the SAP differences in behavior observed here do not seem
to be necessarily related to the induction of a HF diet, since
a work presented by Hartman et al. (2001) showed that 8–11
month old GFAP-ApoE4 mice fed on a normal diet do not
display significant differences in the time spent in the different
arms. However, these mice possess higher SAP time compared
with GFAP-ApoE3 mice (Hartman et al., 2001). The results
described in this study and our own suggest that ApoE4 mice
have low basal levels of anxiety, which are apparent only
in the SAP. However, the ApoE4 mice are prone to mental
stress that can easily be triggered by environmental stimuli
such as consumption of a HF diet, as indicated by higher
freezing levels after presentation of a foot shock and longer
time spent in the closed arms of the EPM. Conflicting evidence
is apparent in regard to the level of basal anxiety in ApoE4
mice. While Johnson et al. (2014) showed differences in basal
anxiety levels related to the E4 allele, Salomon-Zimri et al.
(2014) showed that there were no changes in basal anxiety
levels between the ApoE4 and ApoE3 mice fed on a normal
diet. This could be explained either by the fact that different
protocols were used in the different studies or that the basal
anxiety levels are mild in normal-fed mice and therefore may
not always be apparent. In any case, our results advocate that
the anxiety behavior is worsened with a HF diet specifically in
ApoE4 mice. For this reason the same mice (from the second
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FIGURE 3 | ApoE4 mice develop diabetes mellitus (DM)-like metabolic features following maintenance on a HF diet. (A) ApoE4 mice gained significantly
less weight over a HF diet period of 20 weeks compared to ApoE3 mice (Two-way repeated measures ANOVA, strain effect; F(1,16) = 13.54, #p = 0.0020).
(B) Serum-insulin was extracted and evaluated from 24 h fasted ApoE4 mice and ApoE3 controls after a 23 week HF diet consumption. HF-ApoE4 mice showed
significantly lower levels of serum insulin (1.857 ± 0.3930, n = 10), compared with HF-ApoE3 mice (4.809 ± 0.5133, n = 7; t(15) = 4.643, ∗∗∗p = 0.0003).
(C) Correlation between body weight and serum insulin was evaluated. There was a stronger correlation in HF-ApoE4 mice (R2 = 0.7317, **p = 0.0016), compared
to HF-ApoE3 mice (R2 = 0.6297, p = 0.0332). In addition, linear regression test demonstrated significant differences between elevations or intercepts
(F(1,14) = 21.7475, ∗∗∗p = 0.00036), and no differences between slopes (F(1,13) = 2.65066, p = 0.1275). (D) Serum-glucose was extracted from non-fasting ApoE4
and ApoE3 mice after a 20 week HF diet. HF-ApoE4 mice showed significantly higher glucose levels (287.2 ± 19.25, n = 10) compared with HF-ApoE3 age
matched controls (212.1 ± 13.25, n = 7; t(15) = 2.924, ∗∗p = 0.0105). Data are shown as the mean ± SEM. #Relates to the repeated measuring effect of body
weight between the groups (p < 0.05). Correlations were analyzed using the Pearson r test.
batch only) were evaluated for anxiety levels using the EPM,
and were not further tested for memory differences in the
fear conditioning paradigm. It would be vital to evaluate the
effect of genotype vs. the effect of a HF on stress behavior
as well as performance on additional learning and memory
paradigms. This can be done by comparison to additional
groups of naïve mice fed on a normal diet. It should also
be noted that a study by Siegel et al. (2012) showed that
female human-ApoE4 mice express higher measures of anxiety
compared to female human–apoE3 controls, and as a result,
seemed to score better at the hippocampal-dependent learning
of Morris water maze (MWM). On the other hand, another
group detected impairments in the MWM learning paradigm
in male human-ApoE4 vs. male ApoE3 mice with no apparent
anxiety behavior (Salomon-Zimri et al., 2014). These conflicting
results may be due to differences in protocols and gender
of mice.
Our results show no changes in CRF peptide system
mRNAs in the amygdala, however, these were only analyzed in
non-stressed HF-ApoE mice. These mRNAs should be evaluated
in mice after a stressful stimulus such as the foot shock in order
to evaluate whether the stressful behavior is mirrored by changes
in the CRF peptide system in the amygdala.
Work by other groups revealed that although ApoE4 mice
gain less weight after consumption of a HF diet, they display
dysfunctional epididymal adipose tissue, which in turn impairs
the glucose tolerance in these mice (Arbones-Mainar et al., 2008).
In our work, we strengthen the above by showing that ApoE4
mice indeed gain less weight over time and display abnormal
peripheral glucose/insulin levels, suggesting that the e4 allele
together with an imbalanced HF diet is sufficient to induce DM-
like features, which in turn may also render ApoE4 carriers
more susceptible to dementia and AD (Peila et al., 2002; Yang
and Song, 2013). Furthermore, the reduced body weight in
the HF-ApoE4 mice may be in part due to impaired insulin-
stimulated growth and survival signaling. The fact that ApoE4
mice show stronger correlation between body weight and insulin
levels suggests impaired ability to balance insulin levels despite
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FIGURE 4 | HF diet promotes changes in β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) protein expression in the hippocampus
between ApoE3 and ApoE4 mice. Whole hippocampal tissue was punched from ApoE4 and ApoE3 mice after consuming a HF diet for 23 weeks, and analyzed
for protein expression. (A) HF-ApoE4 retained basal-high levels of eukaryotic initiation factor 2 (eIF2α)-phosphorylation in the hippocampus (1.818 ± 0.1171,
n = 14), compared to HF-ApoE3 mice (1.000 ± 0.05911, n = 15, t(27) = 6.367, ∗∗∗∗p < 0.0001). (B) HF diet induced increased protein levels of BACE1 in the
hippocampus of HF-ApoE4 mice (1.521 ± 0.2154, n = 14), compared with HF-ApoE3 mice (1.000 ± 0.07804, n = 13, t(25) = 2.204, ∗p = 0.0369). (C) HF-ApoE4
mice show a stronger tendency to correlation of hippocampal BACE1 protein with amygdala ATF4 mRNA levels (p = 0.0920), compared with HF-ApoE3 mice
(p = 0.6335), using the Pearson r test. Furthermore, differences between elevations are highly significant (F(1,13) = 13.4541, p = 0.002838).
increased body weight. It should be noted that due to the fact that
in the current study normal-diet fed mice were not evaluated, we
cannot exclude the possibility that changes seen in the different
ApoE strains were the result of changes in the ApoE3 mice and
not the ApoE4 mice. For this, more groups should be included.
However, existing data from previous publications, as well as
metabolic data obtained from Harlan Laboratories in C57BL/6
mice, suggest that the changes are indeed specific to the E4
allele.
Genetic association studies and meta-analysis suggest an
association of BACE1 and ApoE4 to impose additional risk
for sporadic AD (Clarimón et al., 2003; Gold et al., 2003;
Kan et al., 2005; Jo et al., 2008). In addition, studies suggest
a possible role of saturated fatty acids as well as DM in
the increased expression of BACE1; one group showed that
conditioned medium from PA-treated astrocytes, caused BACE1
upregulation in cortical neurons (Patil et al., 2006; Zhang et al.,
2009). Another group suggested that type 2 diabetes exacerbates
the generation of A-beta via activation of BACE1 (Zhang et al.,
2009). Importantly, we found HF treated ApoE4 mice possess
increased protein levels of BACE1, the rate limiting enzyme
in APP cleavage to Aβ, in the hippocampus, compared with
HF-ApoE3 mice. We have never been able before to detect
changes in BACE1 levels in normal diet-fed ApoE3 and ApoE4
mice (data not shown). Therefore, although the question of
whether BACE1 levels are decreased in ApoE3 mice or increased
in ApoE4 mice should be further studied using additional
normal-diet fed groups, our previous results and the literature
regarding BACE1 and obesity suggest that the changes are
indeed specific to the E4 allele. Kim et al. (2011) showed
that BACE1 is not altered in an allele specific manner in
ApoE haploinsufficient mice, E3/E3 vs. E4/E4. This suggests
that environmental factors such as nutrition in e4 carriers
affects biochemical factors closely related to the pathology
of AD. In fact, in APP transgenic mice, BACE1 expression
and activity were increased at sites of focal inflammation
before Aβ deposition, suggesting inflammatory processes may
directly promote local production of Aβ (Heneka et al.,
2005).
In order to explicitly determine whether the changes in the
ApoE strains were a result of the HF diet induced, further
analyzing using additional groups of mice fed with a normal diet
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should be considered. However, we believe that essential and
novel data could be concluded from our work here, which may
open new horizons for studying AD progression in ε4 carriers.
In regard to the ApoE4 genotype, our results and the literature
suggest that chronic metabolic burden such as inflammationmay
result in increased BACE1 levels, and as a result, in accumulation
of Aβ peptides with time. In fact, it has been shown that
ApoE4 promotes aggregation and amyloid plaque formation by
displaying a weaker affinity for Aβ peptides than other ApoE
variants (Liu et al., 2007). The exact mechanism by which a HF
diet in combination with ApoE4 induces metabolic stress and
increased BACE1 levels should be further studied. The above also
strengthens the hypothesis that AD-related abnormality starts
long before pathological features are apparent, and that thesemay
be, to some extent, balanced by a healthy nutritional diet.
In the present work we demonstrate how the complex
integration of genetic, metabolic and environmental factors
triggers a vicious cycle having a detrimental effect on mental
stress and cognitive state. In fact, environmental influences on
longevity are of greatest importance. In rats, mice and non-
human primates, caloric restriction prolongs life and retards the
appearance of several conditions associated with aging (Bunout
and Cambiazo, 1999). It would be intriguing to evaluate our
new hypothesis that a balanced, healthy nutrition diet which
meets the individual’s needs in regards to specific genetic and
metabolic profile, may delay some of the early symptoms of
AD.
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